Abstract
Objective
The aim of this study was to investigate the effects of strontium ranelate on insulin like growth factor-1 (IGF-1), leptin and osteocalcin levels in osteoporotic post-menopausal women.
Study design
Thirty-three women were given 2 g/day strontium ranelate for 6 months. Serum IGF-1, leptin and osteocalcin levels were measured before and after the treatment.
Results
Strontium ranelate treatment increased IGF-1 levels significantly (P = 0.02). Leptin and osteocalcin levels did not change significantly before and after the treatment. There was no correlation between basal and 6-months treatment levels of IGF-1 and leptin.
Conclusion
Strontium ranelate increases serum IGF-1 levels in osteoporotic post-menopausal women.
Similar content being viewed by others
References
Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19(1):55–79
Kasukawa Y, Miyakoshi N, Mohan S (2004) The anabolic effects of GH/IGF system on bone. Curr Pharm Des 10(21):2577–2592
Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, Nicole de Talance et al (2002) Serum leptin level is a predictor of bone mineral density in post-menopausal women. J Clin Endocrinol Metab 87(3):1030–1035
Maor G, Rochwerger M, Segev Y, Phillip M (2002) Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Mineral Res 17:1034–1043
Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R (2001) Influence of insulin-like growth factor-1 and leptin on bone mass in healthy post-menopausal women. Bone 28:113–117
Marie PJ (2007) Strontium ranelate: new insights into its dual mode of action. Bone 40(5 Suppl 1):S5–8
Amman P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R (2004) Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 19(12):2012–2020
Celiker R, Arslan S (2000) Comparison of serum insulin-like growth factor-1 and growth hormone levels in osteoporotic and nonosteoporotic post-menopausal women. Rheumatol Int 19:205–208
Kurland ES, Rosen CJ, Comsan F, Mcmahon D, Chan F, Shane E (1997) Insulin like growth factor-1 in men with idiopathic osteoporosis. J Clin Endocr Metab 82(9):2799–2805
Ostrowska Z, Kos-Kudla B, Marek B, Kajdaniuk D, Cielsielska-Kopacz N (2002) Dynamic pattern of IGF-1 and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis. Endocr Regul 36:9–17
Cakmak A, Posacı C, Dogan E, Caliskan S, Guclu S, Altunyurt S (2005) Raloxifene increases serum leptin levels in postmenopausal women: a prospective study. Am J Gynecol Obstet 193:347–351
Torrisi R, Baglietto L, Johansson H, Veronesi G, Bonanni B, Guerrieri-Gonzaga A et al (2001) Effect of raloxifene on IGF-1 and IGFBP-3 in post-menopausal women with breast cancer. Br J Cancer 85:1838–1841
Eng-Wong J, Hursting SD, Venzon D, Perkins SN, Zujewski JA (2003) Effect of raloxifene on insulin-like growth factor I, insulin-like growth factor binding protein-3, and leptin in pre-menopausal women at high risk for developing breast cancer. Cancer Epidemiol Biomarkers Prev 12:1468–1473
Posaci C, Altunyurt S, Islekel H, Onvural A (2001) Effects of HRT on serum levels of IGF-1 in post-menopausal women. Maturitas 40:69–74
Hartmann B, Kirchengast S, Albrecht A, Laml T, Bikas D, Huber J (1995) Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women. Maturitas 22:239–246
Porcile A, Gallardo E, Duarte P, Aedo S (2003) Differential effects on serum IGF-1 of tibolone (5 mg/day) vs combined continuous estrogen/progestagen in post-menopausal women. Rev Med Chil 131(10):1151–1156
Thomas T, Burguera B, Melton LJ, Atkinson EJ, O’Fallon WM, Riggs BL et al (2001) Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29:114–120
Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S et al (2001) Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in post-menopausal women. Clin Endocrinol 55:341–347
Sahin G, Polat G, Bagis S, Milcan A, Bagdatoglu O, Erdogan C et al (2002) Body composition, bone mineral density and circulating leptin levels in post-menopausal Turkish women. Rheumatol Int 47:236–239
Hadji P, Gorke K, Hars O, Bauer T, Emons G, Schulz KD (2000) The influence of hormone replacement therapy (HRT) on serum leptin concentration in post-menopausal women. Maturitas 37(2):105–111
Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC (2004) Effect of hormone replacement therapy and tibolone on serum leptin levels in post-menopausal women. Maturitas 48(2):107–113
Di Carlo C, Tommaselli GA, Pisano G, Nasti A, Rossi V, Palomba S, Nappi C (2000) Serum leptin levels in post-menopausal women: effects of transdermal hormone replacement therapy. Menopause 7(1):36–41
Panidis DK, Rousso DH, Kourtis AI, Stergiopoulos KN, Mavromatidis GA, Katsikis IK (2001) The influence of tibolone upon serum leptin levels in post-menopausal women. Eur J Obstet Gynecol Reprod Biol 96(1):85–87
Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C (2006) Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause 13(4):660–668
Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C, Lorenc R, Pors-Nielsen S, De Vernejoul MC, Roces A, Reginster JY (2002) Strontium ranelate: dose-dependent effects in established post-menopausal vertebral osteoporosis—a 2 year randomized placebo controlled trial. J Clin Endocrinol Metab 87(5):2060–2066
Reginster JY, Deroisy R, Dougados M, Jupsin I, Colette J, Roux C (2002) Prevention of early post-menopausal bone loss by strontium ranelate: the randomized, 2 year, double-masked, dose-ranging, placebo controlled PREVOS trial. Osteoporos Int 13:925–931
Acknowledgments
This research is supported by the Servier Pharmaceutical Company.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gulhan, I., Bilgili, S., Gunaydin, R. et al. The effect of strontium ranelate on serum insulin like growth factor-1 and leptin levels in osteoporotic post-menopausal women: a prospective study. Arch Gynecol Obstet 278, 437–441 (2008). https://doi.org/10.1007/s00404-008-0611-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-008-0611-x